首站-论文投稿智能助手
典型文献
Impact of vaccination on SARS-CoV-2 infection:Experience from a tertiary care hospital
文献摘要:
Ever since the world has been engulfed by the COVID-19 pandemic,caused by SARS-CoV-2 virus,humanity has gone through untold miseries.There has been a widespread impact on health,including substantial mortality and morbidity,especially among older adults and those with pre-existing health conditions[1,2],in addition to serious repercussions for the global economy,and social wellbeing.Despite this devastating spread of the virus,a large number of the population remains non-immune to SARS-CoV-2[3].
文献关键词:
作者姓名:
Nupur Pal;Debalina Nag;Jayeeta Haider;Aritra Biswas;Raja Ray;Avijit Hazra;Chitrita Chatterjee
作者机构:
Department of Microbiology,Institute of Post-Graduate Medical Education&Research,Kolkata,India;Department of Pharmacology,Institute of Post-Graduate Medical Education&Research,Kolkata,India
引用格式:
[1]Nupur Pal;Debalina Nag;Jayeeta Haider;Aritra Biswas;Raja Ray;Avijit Hazra;Chitrita Chatterjee-.Impact of vaccination on SARS-CoV-2 infection:Experience from a tertiary care hospital)[J].亚太热带医药杂志(英文版),2022(02):90-92
A类:
miseries
B类:
Impact,vaccination,SARS,CoV,infection,Experience,from,tertiary,care,hospital,Ever,since,world,has,been,engulfed,by,pandemic,caused,virus,humanity,gone,through,untold,There,widespread,impact,health,including,substantial,mortality,morbidity,especially,among,older,adults,those,existing,conditions,addition,serious,repercussions,global,economy,social,wellbeing,Despite,this,devastating,large,number,population,remains,immune
AB值:
0.729528
相似文献
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
Qiu-Ju Tian;Man Xie;Ji-Tao Wang;Yi Wang;Bei Zhang;Jin-Zhen Cai;Xiao-Long Qi;Wei Rao-Division of Hepatology,Liver Disease Center,The Affiliated Hospital of Qingdao University,Qingdao 266000,China;Department of Organ Transplantation,The Affiliated Hospital of Qingdao University,Qingdao 266000,China;Department of Gastroenterology,The Affiliated Hospital of Qingdao University,Qingdao 266000,China;CHESS-COVID-19 Group,Xingtai People's Hospital,Xingtai 054000,China;Department of Clinical Laboratory,The Affiliated Hospital of Qingdao University,Qingdao 266000,China;Department of Immunology,Qingdao University Medical College,Qingdao 266000,China;CHESS Center,Institute of Portal Hypertension,The First Hospital of Lanzhou University,Lanzhou 730000,China
The rapid and efficient strategy for SARS-CoV-2 Omicron transmission control: analysis of outbreaks at the city level
Zheng Jin-Xin;Lv Shan;Tian Li-Guang;Guo Zhao-Yu;Zheng Pei-Yong;Chen Yue-Lai;Guan Shi-Yang;Wang Wei-Ming;Zhang Shun-Xian-Department of Nephrology, Ruijin Hospital, Institute of Nephrology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research On Tropical Diseases, National Institute of Parasitic Diseases, Shanghai 200025, People’s Republic of China;Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, People’s Republic of China;Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, People’s Republic of China;School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People’s Republic of China;One Health Center, Shanghai Jiao Tong University–The University of Edinburgh, Shanghai 200025, People’s Republic of China
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
SARS-CoV-2 infection induces testicular injury in Rhesus macaque
Mengying Liang;Wanbo Tai;Yunyun Wang;Yulong Dai;Yanfeng Yao;Juan Min;Yiwu Zhou;Liang Liu;Chao Shan;Han Xia;Zhiming Yuan-Key Laboratory of Special Pathogens and Biosafety,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;University of Chinese Academy of Sciences,Beijing 100049,China;Institute of Infectious Diseases,Shenzhen Bay Laboratory,Shenzhen,518069,China;Department of Forensic Medicine,Tongji Medical College of Huazhong University of Science and Technology,Wuhan,430030,China;Wuhan National Biosafety Laboratory,Chinese Academy of Sciences,Wuhan,430073,China;The Core Facility and Technical Support,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan,430061 China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。